JJ Virgin4x NYTimes Best Selling Author, Certified Nutrition Specialist, Fitness Hall of Famer

Taking Away GLP-1's?

10 Feb 2026 · 1 min

Watch on YouTube

0:43

In this brief monologue, the speaker alleges that manufacturers of tirzepatide are actively working to prevent the availability of compounded tirzepatide, including pressuring clinicians who prescribe it. The speaker argues that media narratives are being recycled to create fear around these medications, and suggests that insurance companies may be the hidden drivers of this discourse, aiming to avoid the high long‑term costs of covering tirzepatide for patients.

Chapters

The makers of tirzepatide are really working hard to take away the possibility for us to have access to compounded tirzepatide in an effort to stop compounding pharmacies from making these medications and even threatening, you know, clinicians who are prescribing them. How do these meds have all of this potential to create health and healing? All we are doing is recycling various narratives in the media that create fear. And I was talking actually with a patient about it. I think it's the insurance companies. And I was like, oh my God. They don't want to spend $20,000 a year for the rest of their lives. It's highly likely that they could be the ones that are creating all of this conversation and fear because honestly, I can't find another reason why.